Sign in
4

Changes in Ownership

Traws Pharma, Inc. Filed Acc 0001179110-13-012232

Options or other derivatives

  • President and CEO acquired 105,000 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Kumar Ramesh · President and CEO

Table II: Derivative

2 lines
Date Transaction Shares Exercise Expires Underlying Owned after D/I
2013-07-25 Grant or award : show line 1 in the form Stock Option (right to purchase) +5,000 $15.00 2023-07-25 5,000 5,000 D
2013-07-25 Grant or award : show line 2 in the form Stock Option (right to purchase) +100,000 $15.00 2023-07-25 100,000 100,000 D
Loading xslF345X03/edgar.xml…